Patents by Inventor David Ring
David Ring has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250385526Abstract: A system and method includes suppling power to a utility grid with a plurality of fuel cell power plants, storing power generated by the plurality of fuel cell power plants with an energy storage system including one or more batteries, and maintaining a standby state-of-charge of the one or more batteries of the energy storage system via an energy management system. The system and method further includes generating a load request to at least one of the plurality of fuel cell power plants via the energy management system, comparing the load request to a predetermined limit; and if the load request exceeds the predetermined limit, commanding the at least one of the plurality of fuel cell power plants to ignore the load request for a predetermined amount of time.Type: ApplicationFiled: June 12, 2024Publication date: December 18, 2025Inventors: Gene Moir, III, David Ring
-
Patent number: 12210002Abstract: A fire testing device for testing fire-resistance properties of a test subject includes a cavity, a heat source adapted to heat the cavity, and a removable separation plate configured to subdivide the cavity into a first chamber and a second chamber. The heat source is arranged in the first changer and adapted to preheat the first chamber. The second chamber includes an opening adapted to receive the test subject. A fire-resistance test of the test subject may include activating the removable separation plate to subdivide the cavity into the first chamber and the second chamber, arranging the test subject at an opening of the second chamber, preheating the first chamber to a defined temperature using the heat source, deactivating the removable separation plate to provide an undivided cavity, and sustaining a heat supply to the cavity using the heat source.Type: GrantFiled: August 2, 2019Date of Patent: January 28, 2025Assignee: Dansk Brand—og sikringsteknisk InstitutInventors: Anders Drustrup, David Ring, Jeanne Bjerre Kirk, Dan Hvolgaard Lauridsen
-
Publication number: 20230089825Abstract: A system for generating a shopping checkout list of items selected by a shopper in a store including: in-store security cameras; a cart scanner and a cart analyzer configured to generate a shopping checkout list based on the data received from the cart scanner; and a shopping list builder (SLB) configured to record images from the security cameras of the shopper's activity in the store to form recorded images, wherein, when the SLB requires verification of an item in the generated shopping checkout list, the SLB is further configured to analyze the recorded images to determine selection of an item by a shopper to thereby verify the item on the shopping checkout list.Type: ApplicationFiled: March 4, 2021Publication date: March 23, 2023Inventors: Yair Cleper, David Ring
-
Publication number: 20210302294Abstract: A fire testing device for testing fire-resistance properties of a test subject includes a cavity, a heat source adapted to heat the cavity, and a removable separation plate configured to subdivide the cavity into a first chamber and a second chamber. The heat source is arranged in the first changer and adapted to preheat the first chamber. The second chamber includes an opening adapted to receive the test subject. A fire-resistance test of the test subject may include activating the removable separation plate to subdivide the cavity into the first chamber and the second chamber, arranging the test subject at an opening of the second chamber, preheating the first chamber to a defined temperature using the heat source, deactivating the removable separation plate to provide an undivided cavity, and sustaining a heat supply to the cavity using the heat source.Type: ApplicationFiled: August 2, 2019Publication date: September 30, 2021Inventors: Anders Drustrup, David RING, Jeanne Bjerre KIRK, Dan Hvolgaard LAURIDSEN
-
Patent number: 9796880Abstract: The present invention pertains to a coating composition based on a specific epoxy-functional siloxane oligomer and an amine-functional polyorganosiloxane. The coating composition is suitable for use on substrates subjected to outdoor conditions, in particular conditions where a high durability, a high UV resistance, and good anti-corrosive properties are required.Type: GrantFiled: June 13, 2014Date of Patent: October 24, 2017Assignee: AKZO NOBEL COATINGS INTERNATIONAL B.V.Inventors: Trevor Michael Wills, Doug Beaumont, David Ring, Tobias Stein
-
Publication number: 20160145468Abstract: The present invention pertains to a coating composition based on a specific epoxy-functional siloxane oligomer and an amine-functional polyorganosiloxane. The coating composition is suitable for use on substrates subjected to outdoor conditions, in particular conditions where a high durability, a high UV resistance, and good anti-corrosive properties are required.Type: ApplicationFiled: June 13, 2014Publication date: May 26, 2016Inventors: Trevor Michael WILLS, Doug BEAUMONT, David RING, Tobias STEIN
-
Patent number: 7783552Abstract: An apparatus, method and data structure for procuring and analyzing information, regarding the financial markets and a system to execute financial transactions using Internet-based front end graphics that resembles casino games and betting games. The system provides a comprehensive combination of financial information and transactions in a format that facilitates known and new casino/betting like front end graphics.Type: GrantFiled: February 7, 2006Date of Patent: August 24, 2010Assignee: Tradonomi Ltd.Inventors: Johnathan Assia, Ronen Assia, David Ring
-
Publication number: 20090061995Abstract: Disclosed is an apparatus, method and system for procuring and analyzing information regarding the financial markets. According to further embodiments of the present invention, there may be provided a system to execute financial transactions using Internet-based frontend graphics that resembles wagering games. The system may provide a comprehensive combination of financial information and transactions in a format that facilitates known and new casino/betting like frontend graphics.Type: ApplicationFiled: November 2, 2008Publication date: March 5, 2009Inventors: Jonathan Assia, Ronen Assia, David Ring
-
Publication number: 20090062016Abstract: Disclosed is an apparatus, method and system for procuring and analyzing information regarding the financial markets. According to further embodiments of the present invention, there may be provided a system to execute financial transactions using Internet-based frontend graphics that resembles wagering games. The system may provide a comprehensive combination of financial information and transactions in a format that facilitates known and new casino/betting like frontend graphics.Type: ApplicationFiled: November 2, 2008Publication date: March 5, 2009Inventors: Jonathan Assia, Ronen Assia, David Ring
-
Publication number: 20080275824Abstract: An apparatus, method and data structure for procuring and analyzing information, regarding the financial markets and a system to execute financial transactions using Internet-based front end graphics that resembles casino games and betting games. The system provides a comprehensive combination of financial information and transactions in a format that facilitates known and new casino/betting like front end graphics.Type: ApplicationFiled: February 7, 2006Publication date: November 6, 2008Applicant: Tradonomi Ltd.Inventors: Johnathan Assia, Ronen Assia, David Ring
-
Publication number: 20070031931Abstract: Disclosed is a formulation for targeting an epitope on an antigen expressed in a mammal. The formulation comprises a pharmaceutically acceptable carrier together with a dimeric biosynthetic construct for binding at least one preselected antigen. The biosynthetic construct contains two polypeptide chains, each of which define single-chain Fv (sFv) binding proteins and have C-terminal tails that facilitate the crosslinking of two sFv polypeptides. The resulting dimeric constructs have a conformation permitting binding of a said preselected antigen by the binding site of each said polypeptide chain when administered to said mammal. The formulation has particular utility in in vivo imaging and drug targeting experiments.Type: ApplicationFiled: October 6, 2006Publication date: February 8, 2007Inventors: L. Houston, David Ring
-
Publication number: 20060177454Abstract: A method of inducing an immune response in a patient is provided. The method involves administration of bispecific molecules capable of recognizing and binding Fc?RIII and a second antigen. The second antigen may be a cancer antigen, a viral antigen, a fungal antigen, a bacterial antigen or a toxin. The second antigen may or may not be present at the time the method of the invention is performed.Type: ApplicationFiled: March 28, 2006Publication date: August 10, 2006Inventor: David Ring
-
Publication number: 20060147444Abstract: Disclosed is a formulation for targeting an epitope on an antigen expressed in a mammal. The formulation comprises a pharmaceutically acceptable carrier together with a dimeric biosynthetic construct for binding at least one preselected antigen. The biosynthetic construct contains two polypeptide chains, each of which define single-chain Fv (sFv) binding proteins and have C-terminal tails that facilitate the crosslinking of two sFv polypeptides. The resulting dimeric constructs have a conformation permitting binding of a said preselected antigen by the binding site of each said polypeptide chain when administered to said mammal. The formulation has particular utility in in vivo imaging and drug targeting experiments.Type: ApplicationFiled: October 10, 2003Publication date: July 6, 2006Inventors: James Huston, Lou Houston, David Ring, Hermann Oppermann
-
Publication number: 20060089369Abstract: New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.Type: ApplicationFiled: September 6, 2005Publication date: April 27, 2006Applicant: Chiron CorporationInventors: John Nuss, Stephen Harrison, David Ring, Rustum Boyce, Kirk Johnson, Keith Pfister, Savithri Ramurthy, Lynn Seely, Allan Wagman, Manoj Desai, Barry Levine
-
Patent number: 6479284Abstract: A humanized antibody framework motif is described. Preferably, the motif is encoded by the VH gene of K5B8 and the VL gene of TR1.6. This humanized antibody preferably contains the variable region of a tat antibody.Type: GrantFiled: September 12, 2000Date of Patent: November 12, 2002Assignees: Dana-Farber Cancer Institute, Inc., Avant Immunotherapeutics, Inc., Chiron CorporationInventors: Wayne A. Marasco, Joyce Lavecchio, Abner Mhashilkar, Urban Ramstedt, David Ring, Bridget Eberhardt, Julie Porter-Brooks
-
Patent number: 6143873Abstract: This invention relates generally to the field of immunology, in particular that of antibodies and antibody productions. More specifically, this invention relates to bispecific antibodies, the hybrid hybridomas which produce them, the parent hybridomas, the production and selection of the hybridomas and hybrid hybridomas, and the purification of the bispecific antibodies. Specific examples relate to bispecific monoclonal antibodies which recognize both the human multi-drug resistance antigen, P-glycoprotein and human Fc.gamma. receptor III (hFc.gamma.RIII. These bispecific antibodies are useful in killing cancer cells.Type: GrantFiled: June 22, 1999Date of Patent: November 7, 2000Assignee: Chiron CorporationInventors: David Ring, Tian-Xiang Shi
-
Patent number: 6106833Abstract: This invention relates generally to the field of immunology, in particular that of antibodies and antibody productions. More specifically, this invention relates to bispecific antibodies, the hybrid hybridomas which produce them, the parent hybridomas, the production and selection of the hybridomas and hybrid hybridomas, and the purification of the bispecific antibodies. Specific examples relate to bispecific monoclonal antibodies which recognize both the human multi-drug resistance antigen, P-glycoprotein and human Fc.gamma. receptor III (hFc.gamma.RIII). These bispecific antibodies are useful in killing cancer cells.Type: GrantFiled: November 12, 1997Date of Patent: August 22, 2000Assignee: Chiron CorporationInventors: David Ring, Tian-Xiang Shi
-
Patent number: 5959084Abstract: This invention relates generally to the field of immunology, in particular that of antibodies and antibody productions. More specifically, this invention relates to bispecific antibodies, the hybrid hybridomas which produce them, the parent hybridomas, the production and selection of the hybridomas and hybrid hybridomas, and the purification of the bispecific antibodies. Specific examples relate to bispecific monoclonal antibodies which recognize both the human multi-drug resistance antigen, P-glycoprotein and human Fc.gamma. receptor III (hFc.gamma.RIII). These bispecific antibodies are useful in killing cancer cells.Type: GrantFiled: June 7, 1995Date of Patent: September 28, 1999Assignee: Chiron CorporationInventors: David Ring, Tian-Xiang Shi